NCT05535166: Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- State
- Under way
- Phase
- Phase 2
- People
- 130 planned
- Started
- 20 Dec 2022
- Primary completion
- Jul 2035
- Arms
- Cognitive Study Group I (educational video and games)
- Results
- None posted
- 10 Sep 2022: Trial registered
- 20 Dec 2022: Trial started